Literature DB >> 23744532

Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4.

Zeng Li1, Nan Li, Minghua Wu, Xiayu Li, Zhaohui Luo, Xiaoyan Wang.   

Abstract

A previous study demonstrated that miR-126 expression was significantly downregulated in highly metastatic colon cancer cells. This study was to investigate the biological function of miR-126 and its regulation of target genes in colon cancer cells. Quantitative PCR was used to detect miR-126 expression in colon cancer SW480 and SW620 cells. MTT assay was to measure the changed cell viability after miR-126 mimics transfection. Wound healing and Transwell migration and invasion assays measured capacity of tumor cell migration and invasion of SW480 and SW620 cells after miR-126 transfection. Luciferase reporter assay and Western blot were used to assess both transcriptional and expression levels of one of the miR-126 target genes (i.e., CXCR4). Levels of miR-126 expression were lower in colon cancer SW480 and SW620 cells than in the adjacent normal epithelial tissues (P < 0.05). Transfection of miR-126 mimics significantly reduced colon cancer cell viability compared to NC cells (P < 0.05). The wound healing and Transwell migration and invasion assays showed that miR-126 mimics inhibited SW480 and SW620 cell migration and invasion capacity. Bioinformatics predicted that CXCR4 is one of the miR-126 target genes. Indeed, luciferase reporter assay and Western blot confirmed that CXCR4 is a miR-126 target gene. Expression of miR-126 inhibited colon cancer cell viability and reduced tumor cell migration and invasion capacity by its negative regulation of CXCR4 expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23744532     DOI: 10.1007/s11010-013-1707-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.

Authors:  Lauréline Roger; Laurent Jullien; Véronique Gire; Pierre Roux
Journal:  J Cell Sci       Date:  2010-03-23       Impact factor: 5.285

2.  The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells.

Authors:  J Kijowski; M Baj-Krzyworzeka; M Majka; R Reca; L A Marquez; M Christofidou-Solomidou; A Janowska-Wieczorek; M Z Ratajczak
Journal:  Stem Cells       Date:  2001       Impact factor: 6.277

3.  Identification of tissue-specific microRNAs from mouse.

Authors:  Mariana Lagos-Quintana; Reinhard Rauhut; Abdullah Yalcin; Jutta Meyer; Winfried Lendeckel; Thomas Tuschl
Journal:  Curr Biol       Date:  2002-04-30       Impact factor: 10.834

4.  miR-126 regulates angiogenic signaling and vascular integrity.

Authors:  Jason E Fish; Massimo M Santoro; Sarah U Morton; Sangho Yu; Ru-Fang Yeh; Joshua D Wythe; Kathryn N Ivey; Benoit G Bruneau; Didier Y R Stainier; Deepak Srivastava
Journal:  Dev Cell       Date:  2008-08       Impact factor: 12.270

5.  CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion.

Authors:  Shailesh Singh; Udai P Singh; William E Grizzle; James W Lillard
Journal:  Lab Invest       Date:  2004-12       Impact factor: 5.662

6.  MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.

Authors:  M Crawford; E Brawner; K Batte; L Yu; M G Hunter; G A Otterson; G Nuovo; C B Marsh; S P Nana-Sinkam
Journal:  Biochem Biophys Res Commun       Date:  2008-07-03       Impact factor: 3.575

7.  Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.

Authors:  Meike Burger; Aleksandra Glodek; Tanja Hartmann; Anette Schmitt-Gräff; Leslie E Silberstein; Nobutaka Fujii; Thomas J Kipps; Jan A Burger
Journal:  Oncogene       Date:  2003-11-06       Impact factor: 9.867

8.  Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells.

Authors:  Chie Kudo-Saito; Hiromi Shirako; Tadashi Takeuchi; Yutaka Kawakami
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

9.  Endogenous human microRNAs that suppress breast cancer metastasis.

Authors:  Sohail F Tavazoie; Claudio Alarcón; Thordur Oskarsson; David Padua; Qiongqing Wang; Paula D Bos; William L Gerald; Joan Massagué
Journal:  Nature       Date:  2008-01-10       Impact factor: 49.962

10.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

View more
  34 in total

Review 1.  Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology.

Authors:  Ivy Ka Man Law; David Miguel Padua; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-08-03       Impact factor: 4.052

Review 2.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

3.  Induction of Immunogenic Cell Death in Lymphoma Cells by Wharton's Jelly Mesenchymal Stem Cell Conditioned Medium.

Authors:  Daniel Hao Lin; Arijit Biswas; Mahesh Choolani; Chui-Yee Fong; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2017-12       Impact factor: 5.739

4.  miR-126: a potential new key player in hypoxia and reperfusion?

Authors:  Sabina P W Guenther; Sonja Schrepfer
Journal:  Ann Transl Med       Date:  2016-10

Review 5.  An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.

Authors:  Wenhao Weng; Junlan Feng; Huanlong Qin; Yanlei Ma; Ajay Goel
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

6.  miR-126: A novel regulator in colon cancer.

Authors:  Weina Huang; Jie Lin; Hongxuan Zhang
Journal:  Biomed Rep       Date:  2015-12-02

7.  MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1.

Authors:  Xiumin Zhao; Danyang Zhu; Cailing Lu; Dewen Yan; Lifeng Li; Zhoufang Chen
Journal:  Oncol Lett       Date:  2015-12-03       Impact factor: 2.967

8.  A clinicopathological analysis of primary mucosal malignant melanoma.

Authors:  Daisuke Izumi; Takatsugu Ishimoto; Naoya Yoshida; Kenichi Nakamura; Keisuke Kosumi; Ryuma Tokunaga; Hidetaka Sugihara; Hiroshi Sawayama; Ryuichi Karashima; Yu Imamura; Satoshi Ida; Yukiharu Hiyoshi; Shiro Iwagami; Yoshifumi Baba; Yasuo Sakamoto; Yuji Miyamoto; Masayuki Watanabe; Hideo Baba
Journal:  Surg Today       Date:  2014-10-09       Impact factor: 2.549

9.  A promising effect of zerumbone with improved anti-tumor-promoting inflammation activity of miR-34a in colorectal cancer cell lines.

Authors:  Razieh Dehghan; Rezvan Najafi; Farid Azizi Jalilian; Massoud Saidijam; Zahra Radaei; Alireza Zamani; Razieh Ezati; Farzaneh Asna-Ashari; Razieh Amini
Journal:  Mol Biol Rep       Date:  2021-01-04       Impact factor: 2.316

10.  Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.

Authors:  Lei Tian; Weiyu Shan; Yufei Zhang; Yufei Zhnag; Xuejun Lv; Xuehua Li; Caiyun Wei
Journal:  Pathol Oncol Res       Date:  2015-10-09       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.